MAP1LC3B and neoplasm: In this study we have shown that immuno-staining of tumour samples with an apoptosis marker (cleaved caspase-3) and an autophagy marker (LC3B) can predict outcome in neoadjuvant chemotherapy treated oesophageal adenocarcinoma.